期刊文献+

一例复杂性泌尿系感染伴念珠菌尿患儿治疗方案分析

Analysis of Therapeutic Regimen for One Child with Complicated Urinary Tract Infection and Candiduria
下载PDF
导出
摘要 目的分析药师参与的儿童复杂尿路感染伴念珠菌尿的治疗实例,促进抗感染药物合理使用及探讨酸碱化尿液临床意义。方法药师参与难治性儿童泌尿系感染伴念珠菌尿病例治疗,分析治疗过程,并对临床常用的尿液酸碱化意义进行文献检索总结。结果药师对部分抗感染方案给出建议获得采纳后治疗取得进展。针对尿液酸碱化对尿路感染治疗的临床意义提出自己的观点,不再支持碱化尿液辅助治疗念珠菌性尿路感染。结论药师参与临床治疗有助于治疗方案改进,通过文献可为临床合理用药提供参考,纠正不良用药习惯。 Objective To promote the rational use of anti-infective drugs in urinary tract infection and discuss the clinical significance of urine pH change by analyzing the treatment case on a child with complicated urinary tract infection and candiduria participated by pharmacist. Methods The treatment process participated by pharmacist was retrospectively analyzed, and the clinical significance of urine pH change was probed through literature retrieval. Results Some of pharmacist's recommendations were adopted and the treatment outcome was advanced. The pharmacist proposed personal opinion on clinical significance of urine pH change in the treatment of urinary tract infection, no longer supported urine alkalization as auxiliary treatment to candidal urinary tract infections. Conclusion Pharmacist's participating in treatment can contribute to clinical outcome, and correct drug-using habit through evidence-based literature.
出处 《食品与药品》 CAS 2016年第3期203-205,共3页 Food and Drug
关键词 泌尿系感染 念珠菌尿 抗感染治疗 尿液酸化 尿液碱化 urinary tract infection candiduria anti-infection treatment urine acidification urine alkalization
  • 相关文献

参考文献20

  • 1儿童常见肾脏疾病诊治循证指南(试行)(七):泌尿系感染诊断治疗指南[J].中华儿科杂志,2010,48(11):814-816. 被引量:51
  • 2李晓忠,邹敏.复杂性尿路感染的诊断及治疗[J].实用儿科临床杂志,2009,24(5):398-400. 被引量:13
  • 3胡付品,朱德妹,汪复,蒋晓飞,徐英春,张小江,张朝霞,季萍,谢轶,康梅,王传清,王爱敏,徐元宏,沈继录,孙自镛,陈中举,倪语星,孙景勇,褚云卓,田素飞,胡志东,李金,俞云松,林洁,单斌,杜艳,韩艳秋,郭素芳,魏莲花,吴玲,张泓,孔菁,胡云建,艾效曼,卓超,苏丹虹.2014年CHINET中国细菌耐药性监测[J].中国感染与化疗杂志,2015,15(5):401-410. 被引量:727
  • 4范洪伟,吕玮,吴东,等.热病桑福德抗微生物治疗指南[M].第42版.北京:中国协和医科大学出版社,2013:35.
  • 5Hsueh P R, Hoban D J, Carmeli Y, et al. Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region[J]. J lnfect, 2011, 63(2): 114-123.
  • 6中华医学会“念珠菌病诊治策略高峰论坛”专家组.念珠菌病诊断与治疗:专家共识[J].中国感染与化疗杂志,2011,2(11):81-83.
  • 7Fisher J F, Sobel J D, Kauffman C A, et al. Candida urinary tract infections-treatment[J]. Clin Infect Dis, 2011, 52 Suppl 6: S457-466.
  • 8Sobel J D, Kauffman C A, McKinsey D, et al. Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo[J]. Clin InfectDis, 2000, 30 (1): 19-24.
  • 9Revankar S G, Hasan M S, Revankar V S, et al. Long-term follow- up of patients with candiduria[J]. Eur J Clin Microbiol Infect Dis, 2011, 30(2): 137-140.
  • 10Kaye D. Antibacterial activity of human urine[J]. J Clin Invest, 1968,47(10): 2374-2390.

二级参考文献19

  • 1金艳,张宏,乔建军.两种培养基体外诱导白念珠菌菌丝相形成的比较[J].中华皮肤科杂志,2005,38(8):501-502. 被引量:9
  • 2Hoffler D. Control and duration of therapy in complicated UTI - with special consideration of C - reactive protein [ J ]. Infection, 1994,22 (suppl 1 ) :53 -54.
  • 3Kromamm -Andersen B, Sommer P, Pers C, et al. Clinical evaluation of ofloxacin versus ciprofloxacin in complicated urinary tract infections [ J ]. Infection, 1986,14 ( suppl 4 ) : 305 - 306.
  • 4Falagas ME, Karageorgopoulos DE. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram negative bacilli: need for international harmonization in terminology[J]. Clin Infect Dis, 2008, 46(7): 1121-1122.
  • 5Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Twenty fourth informational supplement, 2014, M100-S24.
  • 6Hu F, Chen S, Xu X, et al. Emergence of carbapenem- resistant Enterobacteriaceae clinical isolates from a teaching hospital in Shanghai, China[J]. J Med Microbiol, 2012, 61 (Pt 1): 132-136.
  • 7Van Duin D, Kaye KS, Neuner EA, et al. Carbapenem-resistant Enterol2acteriaceae= a review of treatment and outcomes [J]. Diagn Microbiol Infect Dis, 2013, 75(2): 115-120.
  • 8Daikos GL, Tsaousi S, Tzouvelekis LS, et al. Carbapenemase- producing Klebsiella tmeumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems[J]. Antimicrob Agents Chemother, 2014, 58 (4): 2322-2328.
  • 9Tascini C, Jagliaferri E, Giani T, et al. Synergistic activity of colistin plus rifampin against colistin resistant KPC producing Klebsiella pneumoniae [J]. Antimicrob Agents Chemother, 2013, 57(8): 3990-3993.
  • 10Tzouvelekis LS, Markogiannakis A, Psichogiou M, et al. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions [J]. Clin Microbiol Rev, 2012, 25(4): 682-707.

共引文献792

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部